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Abstract—Tris(trimethylsilyl)silane (TTMSS) and azobisisobutironitrile (AIBN) promote the intramolecular heteroarylation of
arenesulfonamides with pyridyl radicals under thermal conditions. The arenesulfonamides are easily prepared from pyridinium N-2 0-
pyridylaminide. The heteroarylation process involves pyridyl radical cyclization and ipso substitution.
q 2004 Elsevier Ltd. All rights reserved.1. Introduction
Azinium N-ylides, a subgroup of mesomeric betaines, are
interesting compounds due to their dipolar character, as well
as to their biological properties and synthetic applications.1,2
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nide, 1a (Scheme 1), a stable heterocyclic betaine, that has a
p-deficient pyridinium fragment attached to a p-excessive
2-iminopyridine moiety. This compound has proven to be a
versatile scaffold in a wide range of transformations. Thus,
for example, the preparation of 3-or 3,5-halogenated 2-alkyl
aminopyridines from 1a can be carried out by an easy and
selective halogenation at the iminopyridine moiety (for
supply, for example 1b, Scheme 1), followed by regio-
selective N-alkylation at the aminide nitrogen and final
reduction of N–N bond.3
During the course of our studies on the intramolecular
arylation of 1b, we evaluated the behavior of the pyridyl
radical 2 (Scheme 1). The ultimate goal was the preparation
of bipyridine 3 by a reaction pathway involving a exo/endo-
trig cyclization, followed by N–N bond breaking, as
previously described.3d Compound 3, however, was not
detected and instead, the tricyclic derivative 4 was obtained
in moderate yield.4 Following the same target in the
development of a preparation of bipyridines and related
biaryls by intramolecular radical arylation (i.e., 5, Scheme 1),
we decided to prepare salt 6 in order to explore the
feasibility of an intramolecular free radical ipso-substitution
of the corresponding arenesulfonamides by pyridyl radicals,
according to the methodology described by Motherwell and
col.5 This well-established method, based on aryl radical
cyclizations, has been applied to the synthesis of biaryls and
arylheterocycles. However, to the best of our knowledge,
references concerning the use of heteroaryl radicals in such
a method have not been published to date. Indeed, from a
general point of view, the cyclization of pyridyl radicals has
scarcely been exploited in synthesis.6Tetrahedron 60 (2004) 11843–11850
Table 1. Arenosulfonamides salts 6 were obtained
Entry Compound Ara Yield (%)
1 6a C6H5 79
2 6b 4-Me–C6H4 66
3 6c 4-MeO–C6H4 46
4 6d 4-Cl–C6H4 53
5 6e 4-NO2–C6H4 65
a Method A: aryl sulfonyl chloride (3 equiv) in acetone (15 mL) to a stirred
solution of 1b (1 equiv) in acetone (5 mL), stirring was then maintained
for 24 h.
A. Sa´nchez et al. / Tetrahedron 60 (2004) 11843–1185011844On the other hand, reductive cyclization of N-(2-halo-
aryl)arenesulfonamides has been studied by Motherwell in
the first instance, in the presence of tributyltin hydride/
AIBN,5 which later obviated the need for tin derivatives
by using arenesulfonylaminobenzene-diazonium salts
and TiCl3.
7 More recently, Togo and Ryokawa reported a
similar tin-free cyclization of bromoaryl arenesulfonamides,
using 1,1,2,2 tetraphenyl disilane, in the presence of AIBN.8
The 1,5-ipso-substitution approach to biaryls compounds
5 is shown in Scheme 2, via 1, while via 2, shows the
alternative 1,6-cyclization to yield the by-products 7. Both
of processes occur according to the reaction mechanism
described by Motherwell and colleagues.5 
 
Scheme 2.As a continuation of our interest in inter- and intramolecular
radical heteroarylations of aromatic substrates, using
Tris(trimethylsilyl)silane (TTMSS)/AIBN, under reductive
conditions, we wish to report our preliminary results
concerning pyridyl radical cyclizations, onto arenesulfona-
mide derivatives, using N-2 0-pyridylaminide, 1a, as starting
material.2. Results and discussion
Pyridyl-substituted aminide 1b (Scheme 3),3c was reacted
with the corresponding aryl sulfonyl chlorides to produce
N-[(3-bromo-5-chloro-pyridin-2-yl)arenesulfonamido] pyri-
dinium chlorides 6. Best results were obtained for
compounds 6a–e (Table 1, entries 1–5) by addition, at
room temperature, of a solution of corresponding aryl
sulfonyl chloride (3 equiv) in acetone (15 mL) to a stirred
solution of 1b (1 equiv) in acetone (5 mL). Stirring was then
maintained for 24 h (method A). The method, however, did
not produce detectable yields of 6 with other aryl sulfonyl
chlorides such as 2,4,6-trimethylbenzenesulfonyl chloride,Scheme 3.quinoline 8-sulfonyl chloride or thiophene-2-sulfonyl chlor-
ide, even refluxing toluene for 48 h (method B).
Having obtained substrates 6, initial experiments on pyridyl
radical cyclization were undertaken on 6a, bearing in mind
the results of previous work on the intramolecular process.4
Thus, as indicated in Scheme 4, the very slow dropwise
addition (syringe pump) of a solution of TTMSS (2 equiv)
and AIBN (2 equiv) to a solution of 6a in benzene/
acetonitrile did not generate detectable yields of 8 and
only poor yields of tricyclic derivative 4 could be obtained.
Similar results were found when the reaction was carried out
in m-xylene, which was used as an alternative to avoid the
use of benzene.8 As a result, the suggested reaction
mechanism would involve N–S fission and subsequent
5-exo/endo-trig cyclization, or alternatively radical cycliza-
tion followed by desulfonylation, both consistent with the
formation of ylide 1b in the absence of TTMSS and AIBN
(Scheme 4).4Scheme 4.Cyclization of compound 6a did not seem to be an efficient
process, so N–N reduction of 6 was performed. The use of a
two molar excess of reducing agents [method C, 6
(0.5 mmol), Pt/C 5% (240 mg), formic acid 96% (1.6 mL,
40 mmol), triethylamine (15 mL, 108 mmol)] on the
previously described method,3c gave N-unsubstituted com-
pounds 9. These results are shown in Scheme 5 and Table 2.
The process, when applied to pyridinium salts 6a–d,
Scheme 5.
Table 2. Compounds 9 and 11 were obtained
Entry R1 Starting material 9, Yield (%) Method 11, Yield (%) Method
1 H 6a 70 Ca 72 Eb
2 CH3 6b 82 C
a 60 Eb
3 OCH3 6c 54 C
a 96 Eb
4 Cl 6d 54 Ca 71 Eb
5 NO2 6e 4 C
a 61 Eb
6 NO2 6e 70 D
c
a Method C: 6 (0.5 mmol), Pt/C 5% (240 mg), formic acid 96% (1.6 mL,40 mmol), triethylamine (15 mL, 108 mmol)), 0–4 8C.
b Method E: 9 (5 mmol), K2CO3 (10 mmol), MeI (15 mmol) in acetone (20 mL), RT, 24 h.
c Method D: 6e (0.5 mmol) in EtOH (6 mL), Et3B (1 M, 0.85 mL), RT, 24 h.
A. Sa´nchez et al. / Tetrahedron 60 (2004) 11843–11850 11845produced arenesulfonamides 9a–d (Table 2, entries 1–4) in
good yields. As expected, reduction of 6e, (R1ZNO2)
produced simultaneous reduction of the nitro group and only
4% of compound 9e was isolated (entry 5). Finally, the
product 9e was satisfactorily obtained (70%), in the
presence of BEt3/EtOH, at room temperature (entry 6,
method D). The process, probably, involves in situ
generation of ethoxydiethylborane as previously described.9 
Scheme 6.
Table 3. Compounds 5 and 7 were obtained
Entry R1 Starting material 5, Yield (
1 H 11a 25
2 H 11a 28
3 H 11a 67
4 H 11a 11
5 H 11a 17
6 CH3 11b 63
7 OCH3 11c 60
8 Cl 11d 50
9 NO2 11e 33
10 H 9a
a Method F: AIBN (2 mmol) in m-xylene (10 mL) was added over 20 h to a stirre
(2 mL); after 7 h, TTMSS (2 mmol) in one portion was added, 80 8C for futher
b Method G: AIBN (2 mmol) and TTMSS (4 mmol) in m-xylene (10 mL) was ad
(2 mL), 80 8C for futher 24 h.
c Method H: AIBN (2 mmol) and TTMSS (4 mmol) in m-xylene (10 mL) was ad
(2 mL), 80 8C for futher 24 h.
d Method I: AIBN (2 mmol) and TTMSS (2 mmol) in m-xylene (10 mL) was add
(2 mL), 80 8C for futher 24 h.
e Method J: AIBN (2 mmol) and TTMSS (4 mmol) in m-xylene (20 mL) was add
(2 mL), 80 8C for futher 24 h.Once again, application of the radical cyclization process,
under similar experimental conditions, to 9a, which has a
N–H free sulfonamide, did not generate the rearranged
biaryl 5. In this case, only the cyclization 7f and the
reduction products 10 were obtained in moderate yields, a
situation in agreement with the results reported for other
radical arylations,5,8 (see Scheme 6 and Table 3, entry 10).
As an alternative, compounds 11 were prepared by
N-methylation with methyl iodide/potassium carbonate(method E). Results are summarized in Scheme 5 and
Table 2.
Optimal conditions for radical ipso-substitution with
TTMSS and AIBN were studied and the results are shown
in Scheme 6 and Table 3. AIBN (2 mmol) in m-xylene
(10 mL) was added dropwise over 20 h to a stirred solution,
at 80 8C, of 11a (0.5 mmol) and TTMSS (2 mmol) in
m-xylene (2 mL). After 7 h, additional TTMSS (2 mmol)
was added in one portion. When the addition was complete,
the mixture was stirred at the same temperature, for a further
24 h. In this case, cyclized 7a (48%) and the desired
compound 5a (25%) were obtained (Table 3, entry 1,
method F). Similar results were observed on slow addition
of TTMSS (entry 2, method G). The best results were
obtained by slow addition (29 h) of a solution of AIBN
(2 mmol) and TTMSS (4 mmol) in m-xylene (10 mL) to a
stirred solution, at 80 8C, of 11a (0.5 mmol) in m-xylene
(2 mL) (entry 3, method H). The reaction did not go to
completion (40% starting material was recovered%) 7, Yield (%) 10, Yield (%) Method
48 — Fa
34 Gb
20 — Hc
40 Id
57 Je
18 Hc
13 Hc
20 Hc
— Hc
33 7 Hc
d solution at 80 8C, of 11a (0.5 mmol) and TTMSS (2 mmol) in m-xylene
24 h.
ded over 20 h to a stirred solution at 80 8C of 11a (0.5 mmol) in m-xylene
ded over 29 h to a stirred solution at 80 8C of 11 (0.5 mmol) in m-xylene
ed over 29 h to a stirred solution at 80 8C of 11a (0.5 mmol) in m-xylene
ed over 29 h to a stirred solution at 80 8C of 11a (0.5 mmol) in m-xylene
A. Sa´nchez et al. / Tetrahedron 60 (2004) 11843–1185011846unchanged) when only 2 equiv of TTMSS (1 mmol) were
used (entry 4, method I). When the reaction was carried out
in more diluted conditions (entry 5, method J) only 17%
yield of substituted compound 5a was detected.
Method H was also applied to compounds 11b–e and the
results are summarized in Table 3 (entries 6–9). When the
reaction was carried out using 11e as the starting material
(entry 9), the reaction mixture appeared very complex and
only 5e was obtained, albeit in poor yield. In general terms,
the presence of an electron-withdrawing substituents in the
para-position of the sulfonyl group led to lower yields in
the ipso-substitution product (entries 8 and 9, Table 3). In
contrast, an electron-donating substituent on the benzene-
sulfonyl moiety produced higher yields of derivatives 5.
Additionally, the p-excessive character of 2-azinylimino-
pyridine moiety on the heterocyclic side, seems to facilitate
the rearrangement to biaryls, both effects being in agree-
ment with previously reported ipso-substitutions in
arenesulfonamides.83. Conclusions
Pyridinium N-2 0-pyridylaminide is a suitable starting
material to produce halo pyridin-2-yl benzenesulfonamides
through halogenation, sulfonylation and N–N reduction
in very mild conditions. The method, combined with
N-methylation and cyclization, by a radical ipso-substi-
tution mechanism, in the presence of TTMSS/AIBN, yields
3-aryl-2-aminopyridines in good yield. In agreement with
previously reported observations, the presence of electron-
donating substituents on both aromatics rings seems to
facilitate the rearrangement to biaryls.4. Experimental
General methods. All experiments were carried out under a
dry argon atmosphere, with solvents freshly distilled under
anhydrous conditions, unless stated otherwise. All chemi-
cals were purchased from the Aldrich Chemical Company
and Fluka, and were used without further purification. 1H,
13C NMR and decoupled spectra were recorded on a Varian
UNITY 300 MHz or VARIAN UNITY PLUS 500 MHz
spectrometer. Mass spectra were recorded on a VG AutoSpec
(Micromass Instruments). Elemental analysis was performed
on a LECO instruments CHNS-932. Pyridinium N-aminides
1a3b and 1b3c have been previously described.
4.1. Reaction de aminide 1b with arene sulfonyl chlorides
General method, method A. To a solution of aminide 1b
(0.285 g, 1 mmol) in acetone (5 mL) was added the
corresponding sulfonyl chloride (3 mmol for compounds
6a,b,d,e and 6 mmol for compound 6c) The mixture was
stirred at room temperature until starting material could not
be detected by TLC (24 h for compounds 6a–d and only 1 h
for compound 6e). The resulting solid was filtered off and
washed with dry acetone.
4.1.1. N-[Benzenesulfonyl-(3 0-bromo-5 0-chloro-pyridin-
2-yl)amino] pyridinium chloride 6a. White solid(364 mg, 79%), mp 170–175 8C; 1H NMR (300 MHz,
CD3OD) d 9.34 (d, 2H, JZ6.2 Hz), 8.90 (t, 1H, JZ
8.0 Hz), 8.65 (d, 1H, JZ1.8 Hz), 8.58 (d, 1H, JZ1.8 Hz),
8.45 (at, 2H, JZ7.7 Hz), 7.98 (t, 1H, JZ7.6 Hz), 7.82 (d,
2H, JZ7.6 Hz), 7.76 (at, 2H, JZ7.6 Hz); MS (ESI) m/z
(relative intensity) 424, 426, 428 [(MC) 92, 100, 41], 284,
286, 288 (23, 30, 8); Anal. Calcd for C16H12BrCl2N3O2S
461.17: C, 41.67; H, 2.62; N, 9.11; S, 6.95%. Found: C,
41.93; H, 2.77; N, 9.41; S, 6.84%.
4.1.2. N-[(3 0-Bromo-5 0-chloro-pyridin-2-yl)(toluene-4 00-
sulfonyl)-amino] pyridinium chloride 6b. White solid
(314 mg, 66%), mp 175–180 8C; 1H NMR (300 MHz,
CD3OD) d 9.18 (d, 2H, JZ5.5 Hz), 8.76 (t, 1H, JZ
7.8 Hz), 8.52 (d, 1H, JZ2.2 Hz), 8.44 (d, 1H, JZ2.2 Hz),
8.12 (dd, 2H, JZ7.8, 5.5 Hz), 7.56 (d, 2H, JZ8.4 Hz), 7.44
(d, 2H, JZ8.4 Hz) 2.43 (s, 3H); MS (ESI) m/z (relative
intensity) 438, 440, 442 [(MC) 96, 100, 41], 284, 286, 288
(16, 21, 5); Anal. Calcd for C17H14BrCl2N3O2S 475.19: C,
42.97; H, 2.97; N, 8.84; S, 6.75%. Found: C, 42.93; H, 2.78;
N, 8.61; S, 6.84%.
4.1.3. N-[(3 0-Bromo-5 0-chloro-pyridin-2-yl)(4 00-methoxy-
benzenesulfonyl)-amino] pyridinium chloride 6c. White
solid (319 mg, 65%), mp 115–120 8C; 1H NMR (300 MHz,
CD3OD) d 9.31 (dd, 2H, JZ5.5, 1.2 Hz), 8.88 (tt, 1H, JZ
6.7, 1.2 Hz), 8.65 (d, 1H, JZ2.2 Hz), 8.56 (d, 1H, JZ
2.2 Hz), 8.26 (dd, 2H, JZ6.7, 5.5 Hz), 7.74 (d, 2H, JZ
7.1 Hz), 7.22 (d, 2H, JZ7.1 Hz), 4.00 (s, 3H); MS (ESI) m/z
(relative intensity) 454, 456, 458 [(MC) 73, 100, 31], 284,
286, 288 (9, 11, 3); Anal. Calcd for C17H14BrCl2N3O3S
491.19: C, 41.57; H, 2.87; N, 8.55; S, 6.82%. Found: C,
41.63; H, 2.70; N, 8.31; S, 6.85%.
4.1.4. N-[(3 0-Bromo-5 0-chloro-pyridin-2-yl)(4 00-chloro-
benzenesulfonyl)-amino] pyridinium chloride 6d. White
solid (263 mg, 53%), mp 115–120 8C; 1H NMR (300 MHz,
CD3OD) d 9.36 (d, 2H, JZ6.3 Hz), 8.92 (t, 1H, JZ7.7 Hz),
8.66 (d, 1H, JZ1.3 Hz), 8.58 (d, 1H, JZ1.3 Hz), 8.30 (dd,
2H, JZ7.7, 6.3 Hz), 7.80 (m, 4H); MS (ESI) m/z (relative
intensity) 458, 460, 462 [(MC) 83, 100, 76], 284, 286, 288
(16, 21, 5); Anal. Calcd for C16H11BrCl3N3O2S 495.61: C,
38.78; H, 2.24; N, 8.48; S, 6.47%. Found: C, 38.68; H, 2.50;
N, 8.38; S, 6.66%.
4.1.5. N-[(3 0-Bromo-5 0-chloro-pyridin-2-yl)(4 00-nitro-
benzenesulfonyl)-amino] pyridinium chloride 6e. White
solid (329 mg, 65%), mp 115–120 8C; 1H NMR (300 MHz,
CD3OD) d 9.40 (dd, 2H, JZ6.6, 1.1 Hz), 8.94 (tt, 1H, JZ
7.8, 1.1 Hz), 8.66 (d, 1H, JZ2.1 Hz), 8.62 (d, 1H, JZ
2.1 Hz), 8.56 (d, 2H, JZ6.9 Hz), 8.30 (dd, 2H, JZ7.8,
6.6 Hz), 8.10 (d, 2H, JZ6.9 Hz); MS (ESI) m/z (relative
intensity) 469, 471, 473 [(MC) 72, 100, 35], 284, 286, 288
(26, 33, 10); Anal. Calcd for C16H11BrCl2N4O4S 506.16: C,
37.97; H, 2.19; N, 11.07; S, 6.34%. Found: C, 38.09; H,
2.26; N, 11.38; S, 6.55%.
4.2. Reduction of substituted N-arenesulfonyl
N-(30-bromo-5 0-chloro-pyridin-2-yl) pyridiniumchlorides
General method, method C. Platinum on charcoal (5%)
(240 mg) was suspended in a solution of the pyridinium
salts (0.5 mmol) in CH3CN (12 mL) and cooled in an ice
A. Sa´nchez et al. / Tetrahedron 60 (2004) 11843–11850 11847bath. A solution of formic acid (96%, 1.6 mL) in CH3CN
(5 mL) and then triethylamine (15 mL) in the same solvent
(12 mL) were added dropwise. The resulting suspension
was allowed to warm up to room temperature and filtered
through Celite. The filtrate was evaporated and the residue
dissolved in water, made basic with solid K2CO3 and
extracted with ethyl acetate. The combined organic phases
were dried over Na2SO4, filtered and evaporated to dryness.
The corresponding benzenesulfonamide was purified by
flash chromatography and crystallization from diethyl
ether/hexanes.
4.2.1. N-(3-Bromo-5-chloro-pyridin-2-yl)benzenesul-
fonamide 9a. The general procedure (method C) using 6a
(231 mg) as the starting pyridinium salt gave, after flash
chromatography and crystallization [silicagel, hexanes/
ethyl acetate (80:20), Rfz0.48], a white solid (122 mg,
70%), mp 146–147 8C; 1H NMR (500 MHz, CDCl3) d 8.11
(d, 2H, JZ7.4 Hz), 8.10 (d, 1H, JZ2.1 Hz), 7.75 (d, 1H,
JZ2.1 Hz), 7.58 (t, 1H, JZ8.0 Hz), 7.48 (dd, 2H, JZ8.0,
7.4 Hz); 13C NMR (75 MHz, CDCl3) d 146.4, 145.2, 141.8,
140.1, 133.4, 133.0, 128.6, 128.4, 107.0; MS (EI) m/z
(relative intensity) 346, 348, 350 [(MC), 0.4, 0.6, 0.2],
281, 283, 285 (27, 35, 9), 77 (100); Anal. Calcd for
C11H8BrClN2O2S 347.62: C, 38.01; H, 2.32; N, 8.06; S,
9.22%. Found: C, 37.72; H, 2.56; N, 7.88; S, 9.16%.
4.2.2. N-(3-Bromo-5-chloro-pyridin-2-yl)-4 0-methyl-ben-
zenesulfonamide 9b. The general procedure (method C)
using 6b (238 mg) as the starting pyridinium salt gave,
after flash chromatography and crystallization [silica gel,
hexanes/ethyl acetate (70:30), Rfz0.28], a white solid
(148 mg, 82%), mp 136–138 8C; 1H NMR (300 MHz,
CDCl3) d 8.12 (d, 1H, JZ2.1 Hz), 7.98 (d, 2H, JZ8.2 Hz),
7.74 (d, 1H, JZ2.1 Hz), 7.62 (bs, 1H), 7.28 (d, 2H, JZ
8.2 Hz), 2.40 (s, 3H); 13C NMR (75 MHz, CDCl3) d 146.3,
145.2, 144.3, 140.0, 136.0, 129.2, 128.5, 125.1, 106.7, 21.7;
MS (EI)m/z (relative intensity) 360, 362, 364 [(MC), 0.4, 0.6,
0.1], 295, 297, 299 (57, 74, 18), 91 (100); Anal. Calcd for
C12H10BrClN2O2S 361.65: C, 39.85; H, 2.79; N, 7.75; S,
8.87%. Found: C, 39.65; H, 2.83; N, 7.48; S, 8.40%.
4.2.3. N-(3-Bromo-5-chloro-pyridin-2-yl)-4 0-methoxy-
benzenesulfonamide 9c. The general procedure (method
C) using 6c (246 mg) as the starting pyridinium salt gave,
after flash chromatography and crystallization [silica gel,
hexanes/ethyl acetate (70:30), Rfz0.45], a white solid
(102 mg, 54%), mp 155–158 8C; 1H NMR (300 MHz,
CDCl3) d 8.09 (d, 1H, JZ2.0 Hz), 8.02 (d, 2H, JZ
8.9 Hz), 7.70 (d, 1H, JZ2.0 Hz), 6.92 (d, 2H, JZ8.9 Hz),
5.00 (bs, 1H), 3.81 (s, 3H); 13C NMR (75 MHz, CDCl3) d
163.4, 146.5, 145.2, 140.0, 134.6, 130.7, 125.5, 113.7,
106.6, 55.5; MS (EI) m/z (relative intensity) 311, 313, 315
(74, 100, 27), 171 (27), 107 (11), 77 (86); Anal. Calcd for
C12H10BrClN2O3S 377.65: C, 38.17; H, 2.67; N, 7.42; S,
8.49%. Found: C, 38.33; H, 2.77; N, 7.41; S, 8.24%.
4.2.4. N-(3-Bromo-5-chloro-pyridin-2-yl)-4 0-chloro-ben-
zenesulfonamide 9d. The general procedure (method C)
using 6d (248 mg) as the starting pyridinium salt gave, after
flash chromatography and crystallization [silica gel, hex-
anes/ethyl acetate (70:30), Rfz0.37], a white solid (103 mg,
54%) mp 145–148 8C; 1H NMR (300 MHz, CDCl3) d 8.09(d, 1H, JZ2.0 Hz), 8.05 (d, 2H, JZ8.5 Hz), 7.74 (d, 1H,
JZ2.0 Hz), 7.44 (d, 2H, JZ8.5 Hz), 5.00 (bs, 1H); 13C
NMR (75 MHz, CDCl3) d 146.3, 145.2, 140.3, 139.9,
137.7, 130.0, 128.9, 126.0, 106.9; MS (EI) m/z (relative
intensity) 315, 317, 319 (61, 100, 46), 111 (73), 75 (43);
Anal. Calcd for C11H7BrCl2N2O2S 382. 06: C, 34.58; H,
1.85; N, 7.33; S, 8.39%. Found: C, 34.75; H, 1.90; N, 7.37;
S, 8.01%.
4.2.5. N-(3-Bromo-5-chloro-pyridin-2-yl)-4 0-nitro-ben-
zenesulfonamide 9e. The general procedure (method C)
using 6e (253 mg) as the starting pyridinium salt gave, after
flash chromatography and crystallization (silica gel, hex-
anes/ethyl acetate (70:30), Rfz0.31), a white solid (8 mg,
4%). Method D. Compound 6e (0.5 mmol, 253 mg) was
dissolved in EtOH (6 mL). The solution was flushed with
argon and stirred at room temperature. A solution of
triethylborane in hexane (1.0 M, 0.85 mL, 0.85 mmol) was
then added dropwise. After stirring for 2 h at room
temperature, air (0.85 mL) was added with a syringe and
stirring was maintained at the same temperature for further
24 h. Purification by flash chromatography and crystal-
lization furnished 9e (137 mg, 70%), mp 202–203 8C; 1H
NMR (300 MHz, CDCl3) d 8.34 (d, 2H, JZ6.8 Hz), 8.32 (d,
2H, JZ6.8 Hz), 8.11 (d, 1H, JZ2.4 Hz), 7.79 (d, 1H, JZ
2.4 Hz), 7.68 (bs, 1H); MS (EI) m/z (relative intensity) 326,
328, 330 (76, 100, 26), 282 (35), 248 (23), 208 (53), 76 (41);
Anal. Calcd for C11H7BrClN3O4S 392.62: C, 33.65; H,
1.80; N, 10.70; S, 8.17%. Found: C, 33.32; H, 1.84; N,
10.47; S, 7.98%.
4.3. Reaction of arenesulfonamides with iodomethane
General method, method E: To a dispersion of correspond-
ing N-unsubstituted arenesulfonamide 9a–e (5 mmol) and
potassium carbonate (10 mmol, 1.38 g) in acetone (20 mL),
was added iodomethane (15 mmol, 0.93 mL). The mixture
was stirred at room for 24 h and all starting material was
consumed (TLC analysis). Purification by flash chroma-
tography furnished a white solid, which was crystallized
from hexanes.
4.3.1. N-(3-Bromo-5-chloro-pyridin-2-yl)-N-methyl-ben-
zenesulfonamide 11a. The general procedure (method E)
using 9a (1.738 g) as starting material gave, after flash
chromatography and crystallization [silicagel, hexanes/
ethyl acetate (70:30), Rfz0.86], a white solid (1.310 g,
72%), mp 145–149 8C; 1H NMR (300 MHz, CDCl3) d 8.27
(d, 1H, JZ2.3 Hz), 8.02 (d, 1H, JZ2.3 Hz), 7.83 (d, 2H,
JZ7.5 Hz), 7.62 (t, 1H, JZ7.3 Hz), 7.52 (dd, 2H, JZ7.5,
7.3 Hz), 3.06 (s, 3H); 13C NMR (75 MHz, CDCl3) d 148.9,
144.1, 139.7, 135.3, 131.0, 129.6, 126.6, 126.4, 119.9, 34.8;
MS (EI) m/z (relative intensity) 295, 297, 299 (61, 80, 20),
221 (25), 77 (100); Anal. Calcd for C12H10BrClN2O2S
361.65: C, 39.85; H, 2.79; N, 7.75; S, 8.87%. Found: C,
40.10; H, 2.97; N, 7.70; S, 8.64%.
4.3.2. N-(3-Bromo-5-chloro-pyridin-2-yl)-4 0,N-dimethyl-
benzene sulfonamide 11b. The general procedure (method
E) using 9b (1.808 g) as the starting material gave, after
flash chromatography and crystallization [silicagel, hex-
anes/ethyl acetate (70:30), Rfz0.90], a white solid (1.126 g,
60%), mp 120–125 8C; 1H NMR (300 MHz, CDCl3) d 8.27
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JZ8.2 Hz), 7.30 (d, 2H, JZ8.2 Hz), 3.04 (s, 3H), 2.43 (s,
3H); 13C NMR (75 MHz, CDCl3) d 150.9, 145.9, 143.7,
141.5, 134.1, 131.3, 129.2, 128.4, 121.8, 36.7, 21.6; MS (EI)
m/z (relative intensity) 309, 311, 313 (50, 66, 17), 91 (100);
Anal. Calcd for C13H12BrClN2O2S 375.67: C, 41.56; H,
3.22; N, 7.46; S, 8.54%. Found: C, 41.40; H, 3.39; N, 7.20;
S, 8.71%.
4.3.3. N-(3-Bromo-5-chloro-pyridin-2-yl)-4 0-methoxy-N-
methyl-benzenesulfonamide 11c. The general procedure
(method E) using 9c (1.888 g) as the starting material gave,
after flash chromatography and crystallization [silicagel,
hexanes/ethyl acetate (70:30), Rfz0.40], a white solid
(1.194 g, 61%), mp 122–123 8C; 1H NMR (300 MHz,
CDCl3) d 8.25 (d, 1H, JZ2.2 Hz), 7.99 (d, 1H, JZ
2.2 Hz), 7.72 (d, 2H, JZ8.8 Hz), 6.95 (d, 2H, JZ8.8 Hz),
3.84 (s, 3H), 3.01 (s, 3H); 13C NMR (75 MHz, CDCl3) d
163.1, 151.2, 146.1, 141.6, 131.3, 130.6, 121.8, 113.8,
109.0, 55.4, 36.6; MS (EI) m/z (relative intensity) 325, 327,
329 (67, 96, 33), 171 (56), 107 (99), 92 (71), 77 (100);
Anal. Calcd for C13H12BrClN2O3S 391.67: C, 39.87; H,
3.09; N, 7.15; S, 8.19%. Found: C, 40.06; H, 3.13; N, 7.12;
S, 7.92%.
4.3.4. N-(3-Bromo-5-chloro-pyridin-2-yl)-4 0-chloro-N-
methyl-benzenesulfonamide 11d. The general procedure
(method E) using 9d (1.910 g) as the starting material gave,
after flash chromatography and crystallization [silicagel,
hexanes/ethyl acetate (70:30), Rfz0.64], a white solid
(1.406 g, 71%), mp 128–130 8C; 1H NMR (300 MHz,
CDCl3) d 8.24 (d, 1H, JZ2.2 Hz), 7.98 (d, 1H, JZ
2.2 Hz), 7.75 (d, 2H, JZ8.5 Hz), 7.46 (d, 2H, JZ8.5 Hz),
3.03 (s, 3H); 13C NMR (75 MHz, CDCl3) d 150.7, 146.1,
141.7, 139.4, 135.9, 131.6, 129.8, 128.9, 121.7, 36.6; MS
(EI) m/z (relative intensity) 329, 331, 333 (53, 86, 40), 111
(100), 75 (90); Anal. Calcd for C12H9BrCl2N2O2S 396.09:
C, 36.39; H, 2.29; N, 7.07; S, 8.10%. Found: C, 36.07; H,
2.37; N, 7.06; S, 7.10%.
4.3.5. N-(3-Bromo-5-chloro-pyridin-2-yl)-N-methyl-4 0-
nitro-benzenesulfonamide 11e. The general procedure
(method E) using 9e (1.910 g) as the starting material
gave, after flash chromatography and crystallization [sili-
cagel, hexanes/ethyl acetate (70:30), Rfz0.83], a white
solid (1.951 g, 96%), mp 137–138 8C; 1H NMR (300 MHz,
CDCl3) d 8.36 (d, 2H, JZ8.7 Hz), 8.26 (d, 1H, JZ2.2 Hz),
8.02 (m, 3H), 3.11 (s, 3H); 13C NMR (75 MHz, CDCl3) d
150.3, 150.2, 146.4, 143.4, 142.1, 132.3, 129.8, 123.9,
121.8, 37.0; MS (EI) m/z (relative intensity) 340, 342, 344
(78, 100, 29), 219, 221, 22 (63, 75, 19), 190, 192, 194 (30,
44, 17); Anal. Calcd for C12H9BrClN3O4S 406.64: C, 35.44;
H, 2.23; N, 10.33; S, 7.89%. Found: C, 35.27; H, 2.33; N,
10.12; S, 7.91%.
4.4. Radical reaction of arenesulfonamides
General method, method H. A solution of TTMSS (0.498 g,
2 mmol) and AIBN (0.328 g, 2 mmol) in m-xylene (10 mL)
was added dropwise by a syringe pump during 29 h to a
stirred solution of appropriate arenesulfonamide (9a or
11a–e, 0.5 mmol) in m-xylene (2 mL), at 80 8C (bath
temperature). Stirring was maintained at the sametemperature for further 24 h, after which the starting
material had been consumed (TLC analysis). The solution
was concentrated and the crude mixture was separated by
flash chromatography [silicagel, hexanes/ethyl acetate
(70:30)], yielding the pure compounds.
4.4.1. (5-Chloro-3-phenyl-pyridin-2-yl)-methyl amine 5a
and 3-chloro-10-methyl-10H-9-thia-1,10-diaza-phenan-
threne 9,9-dioxide 7a. The general procedure (method H)
using 11a as the starting sulfonamide (181 mg) gave a
mixture of products. After separation by flash chromatog-
raphy, pure compounds 5a and 7a were obtained. 5a yellow
oil, Rfz0.39 (73 mg, 67%);
1H NMR (500 MHz, CD3OD) d
7.98 (d, 1H, JZ2.5 Hz), 7.51 (dd, 1H, JZ7.8, 7.3 Hz), 7.44
(tt, 1H, JZ7.3, 1.4 Hz), 7.42 (dd, 1H, JZ7.8, 1.4 Hz), 2.87
(s, 3H); 13C NMR (75 MHz, CD3OD) d 155.2, 144.0, 136.6,
136.5, 130.1, 129.1, 128.7, 128.1, 124.4, 118.7, 28.9; MS
(EI) m/z (relative intensity) 218, 220 [(MC) 11, 4], 202 (2),
217, 219 (20, 4), 128 (31), 111 (24), 82 (66), 58 (100). 7a
White solid, Rfz0.61 (28 mg, 20%, diethyl ether/hexanes),
mp 138–139 8C; 1H NMR (300 MHz, CDCl3) d 8.45 (d, 1H,
JZ2.4 Hz), 8.28 (d, 1H, JZ2.4 Hz), 8.09 (dd, 1H, JZ7.9,
1.3 Hz), 7.94 (d, 1H, JZ8.1 Hz), 7.77 (ddd, 1H, JZ8.1, 7.1,
1.3 Hz), 7.67 (dd, 1H, JZ7.9, 7.1 Hz) 3.63 (s, 3H); 13C
NMR (75 MHz, CDCl3) d 147.7, 147.3, 133.8, 132.6, 132.4,
129.4, 128.8, 126.7, 125.1, 122.4, 118.5, 28.7; MS (EI) m/z
(relative intensity) 280, 282 (16, 6), 215, 217 (100, 37), 73
(16); Anal. Calcd for C12H9ClN2O2S 280.73: C, 51.34; H,
3.23; N, 9.98; S, 11.42%. Found: C, 51.33; H, 2.95; N,
10.06; S, 11.56%.
4.4.2. (5-Chloro-3-p-tolyl-pyridin-2-yl)-methyl-amine 5b
and 3-chloro-6,10-dimethyl-10H-9-thia-1,10-diaza-phe-
nanthrene 9,9-dioxide 7b. The general procedure (method
H) using 11b as the starting sulfonamide (188 mg) gave a
mixture of products. After separation by flash chromatog-
raphy, pure compounds 5b and 7b were obtained. 5b yellow
oil, Rfz0.73 (74 mg, 63%);
1H NMR (300 MHz, CD3OD) d
7.92 (d, 1H, JZ2.5 Hz), 7.27 (m, 4H), 7.24 (d, 1H, JZ
2.5 Hz), 2.83 (s, 3H), 2.38 (s, 3H); 13C NMR (75 MHz,
CD3OD) d 149.1, 144.8, 139.3, 137.5, 134.7, 130.8, 129.6,
121.9, 119.8, 28.9, 21.2; MS (EI) m/z (relative intensity)
231, 232 [(MC) 26, 11], 231, 233 (44, 21), 103 (13). 7b
White solid, Rfz0.65 (26 mg, 18%, diethyl ether/hexanes),
mp 137–139 8C; 1H NMR (300 MHz, CDCl3) d 8.41 (d, 1H,
JZ2.4 Hz), 8.25 (d, 1H, JZ2.4 Hz), 7.96 (d, 1H, JZ
8.1 Hz), 7.71 (bs, 1H, w ½Z2 Hz), 7.45 (dd, 1H, JZ8.1,
2.0 Hz), 3.60 (s, 3H), 2.54 (s, 3H); 13C NMR (75 MHz,
CDCl3) d 147.9, 147.1, 143.5, 132.3, 131.3, 130.2, 128.8,
126.6, 125.4, 122.5, 118.5, 28.4, 21.9; MS (EI) m/z (relative
intensity) 294, 296 [(MC) 17, 3], 229, 231 (100, 30); Anal.
Calcd for C12H11ClN2O2S 294.76: C, 52.97; H, 3.76; N,
9.50; S, 10.88%. Found: C, 52.76; H, 4.01; N, 9.55; S,
10.83%.
4.4.3. [5-Chloro-3-(4-methoxy-phenyl)-pyridin-2-yl]-
methyl-amine 5c and 3-chloro-6-methoxy-10-methyl-
10H-9-thia-1,10-diaza-phenanthrene 9,9-dioxide 7c. The
general procedure (method H) using 11c as the starting
sulfonamide (196 mg) gave a mixture of products. After
separation by flash chromatography, pure compounds 5c
and 7c were obtained. 5c yellow oil, Rfz0.55 (75 mg,
60%); 1H NMR (300 MHz, CD3OD) d 7.91 (d, 1H, JZ
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7.01 (d, 2H, JZ8.8 Hz), 3.82 (s, 3H), 2.83 (s, 3H); 13C
NMR (75 MHz, CD3OD) d 161.2, 156.8, 144.8, 137.6,
131.1, 129.8, 125.5, 119.9, 115.7, 30.6, 24.2; MS (EI) m/z
(relative intensity) 248, 250 [(MCC1) 73, 24], 247, 249
[(MC) 100, 41]. 7c White solid, Rfz0.39 (20 mg, 13%,
diethyl ether/hexanes), mp 174–176 8C; 1H NMR
(300 MHz, CDCl3) d 8.44 (d, 1H, JZ2.4 Hz), 8.21 (d, 1H,
JZ2.4 Hz), 8.00 (d, 1H, JZ8.8 Hz), 7.33 (d, 1H, JZ
2.4 Hz), 7.15 (dd, 1H, JZ8.8, 2.4 Hz), 3.97 (s, 3H), 3.60 (s,
3H); 13C NMR (75 MHz, CDCl3) d 162.8, 148.2, 147.5,
132.5, 132.4, 130.9, 126.6, 124.7, 118.4, 115.2, 109.9, 55.8,
28.3; MS (EI) m/z (relative intensity) 311, 313 [(MCC1) 4,
2], 310, 312 [(MC) 23, 9], 246, 248 (16, 5), 245, 247 (100,
34), 231 (21), 202 (22); Anal. Calcd for C13H11ClN2O3S
310.76: C, 50.24; H, 3.57; N, 9.01; S, 10.32%. Found: C,
50.40; H, 3.64; N, 9.22; S, 10.56%.
4.4.4. [5-Chloro-3-(4-chloro-phenyl)-pyridin-2-yl]-
methyl-amine 5d and 3,6-dichloro-10-methyl-10H-9-
thia-1,10-diaza-phenanthrene 9,9-dioxide 7d. The gen-
eral procedure (method H) using 11d as the starting
sulfonamide (198 mg) gave a mixture of products. After
separation by flash chromatography, pure compounds 5d
and 7d were obtained. 5d yellow oil, Rfz0.71 (58 mg,
46%); 1H NMR (300 MHz, CD3OD) d 7.97 (d, 1H, JZ
2.4 Hz), 7.48 (d, 2H, JZ8.5 Hz), 7.38 (d, 2H, JZ8.5 Hz),
7.28 (d, 1H, JZ2.4 Hz), 2.86 (s, 3H); 13C NMR (75 MHz,
CDCl3) d 156.3, 145.6, 137.7, 136.4, 135.2, 131.5, 130.3,
124.1, 119.9, 28.9; MS (EI) m/z (relative intensity) 252, 254
[(MC) 15, 10], 251, 253 (25, 11), 71 (64), 69 (100), 73 (63).
7d White solid, Rfz0.68 (34 mg, 21%, diethyl ether/
hexanes), mp 137–139 8C; 1H NMR (300 MHz, CDCl3 d
8.44 (d, 1H, JZ1.2 Hz), 8.21 (d, 1H, JZ1.4 Hz), 7.98 (d,
1H, JZ8.4 Hz), 7.87 (d, 1H, JZ1.2 Hz), 7.61 (dd, 1H, JZ
8.4, 1.4 Hz), 3.59 (s, 3H); 13C NMR (75 MHz, CDCl3) d
148.2, 148.0, 139.3, 132.6, 132.3, 130.7, 129.6, 127.0,
125.2, 124.2, 117.6, 28.6; MS (EI) m/z (relative intensity)
314, 316 [(MC) 13, 10], 249, 251 (100, 65); Anal. Calcd for
C12H8Cl2N2O2S 315.18: C, 45.73; H, 2.56; N, 8.89; S,
10.17%. Found: C, 45.94; H, 2.66; N, 8.79; S, 9.98%.
4.4.5. [5-Chloro-3-(4-nitro-phenyl)-pyridin-2-yl]-
methyl-amine 5e. The general procedure (method H)
using 11e as the starting sulfonamide (203 mg) gave a
after purification by flash chromatography, only pure
compound 5e. Yellow solid, Rfz0.54 (43.5 mg, 33%,
hexanes), mp 128–130 8C; 1H NMR (300 MHz, CD3OD)
d 8.00 (d, 1H, JZ2.5 Hz), 7.62 (d, 2H, JZ8.4 Hz), 7.49 (d,
2H, JZ8.4 Hz), 7.36 (d, 1H, JZ2.5 Hz), 2.88 (s, 3H); 13C
NMR (75 MHz, CD3OD) d 156.3, 148.6, 145.6, 137.9,
137.7, 130.3, 127.4, 121.7, 120.0, 28.9; MS (EI) m/z
(relative intensity) 263, 265 [(MC) 3, 1], 248 (100), 247
(55); Anal. Calcd for C12H10ClN3O2 263.69: C, 54.66; H,
3.82; N, 15.94%. Found C, 54.94; H, 3.88; N, 16.17%.
4.4.6. 3-Chloro-10H-9-thia-1,10-diaza-phenanthrene
9,9-dioxide 7f and N-(5-chloro-pyridin-2-yl)benzene-
sulfonamide 10. The general procedure (method H) using
9a as unsubstituted sulfonamide (174 mg) gave a mixture of
products. After separation by flash chromatography, pure
compounds 7f and 10 were obtained. 7f pale yellow solid,
Rfz0.66 (44 mg, 33%, diethyl ether/hexanes), mpO250 8C(dec.); 1H NMR (300 MHz, DMSO-d6) d 8.90 (d, 1H, JZ
2.3 Hz), 8.37 (d, 1H, JZ7.1 Hz), 8.36 (d, 1H, JZ2.3 Hz),
7.94 (dd, 1H, JZ7.4, 1.8 Hz), 7.75 (m, 2H), 4.50 (bs, 1H);
13C NMR (75 MHz, DMSO-d6) d 162.6, 148.8, 135.2,
133.0, 131.3, 129.6, 127.5, 124.7, 121.9, 117.0, 108.2; MS
(EI) m/z (relative intensity) 267, 269 [(MCC1) 9, 4], 266,
268 [(MC) 62, 24], 203, 205 (19, 9), 202, 204 (100, 52), 140
(69), 113 (31); Anal. Calcd for C11H7ClN2SO2 266.71: C,
49.54; H, 2.65; N, 10.50, S, 12.02%. Found C, 49.66; H,
2.84; N, 10.71; S, 11.86%. 10 white solid, Rfz0.62 (10 mg,
7%, hexanes), mp 156–158 8C; 1H NMR (300 MHz, CDCl3)
d 8.40 (d, 1H, JZ2.3 Hz), 8.20 (bs, 1H), 7.81 (d, 2H, JZ
7.1 Hz), 7.62 (dd, 1H, JZ8.5, 2.3 Hz), 7.55 (d, 1H, JZ
8.5 Hz), 7.44 (m, 3H); 13C NMR (75 MHz, CDCl3) d 149.2,
146.9, 139.5, 138.7, 133.3, 133.0, 129.2, 127.0, 113.0; MS
(EI) m/z (relative intensity) 268, 270 [(MC) 3, 1], 203, 205
(60, 21), 77 (100); Anal. Calcd for C11H9ClN2O2S 268.72:
C, 49.17; H, 3.38; N, 10.42; S, 11.93%. Found: C, 48.97; H,
3.65; N, 10.46; S, 12.07%.Acknowledgements
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